Hospitalist Doctors in Edinburg, TX Accepting Medicare

9 Hospitalist doctors found. Showing 1 - 9

Chelsea Chang, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5423 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-362-3575    Fax: 956-362-3584

Dr. David Ramirez Jr., DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5501 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-362-8677    Fax: 956-362-7253

Carlos Alberto Paris, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5501 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-362-8677    Fax: 956-362-7253

Humberto J Chavarria, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5501 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-362-8677

Mr. Ali Hasnain Naqvi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3212 S Sugar Rd, Edinburg, TX 78539 Phone: 956-720-4159    Fax: 956-720-4179

Padmini Bhadriraju, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5215 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-631-7100    Fax: 956-631-5901

Dr. Jorge-jayme Montes, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5501 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-362-8677    Fax: 956-362-7253

Dr. Xavier Blanco Criado, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5501 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-362-8677    Fax: 956-362-7253

Dr. Jose M. Garza, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5501 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-362-8677    Fax: 956-362-7253

News Archive

QR Pharma and MUSC receive $220,000 SBIR grant to study Posiphen in AD transgenic mice

QR Pharma, Inc., a clinical-stage specialty pharmaceutical company committed to developing therapeutics with novel approaches for the treatment of cognitive impairment and Alzheimer's disease and the Medical University of South Carolina (MUSC) announced today that they received a Small Business Innovation Research (SBIR) phase I grant in the amount of $220,000 to study Posiphen® and its metabolites in cell culture and in transgenic Alzheimer mice.

Accelr8 Technology completes sale of non-exclusive license for OptiChem bio-coatings

Accelr8 Technology Corporation today announced that it completed the sale of a non-exclusive license for its proprietary OptiChem bio-coatings to an innovative, public diagnostics company. The licensee is paying $1,865,000 over four annual escalating payments and intends to use OptiChem® in its disposable diagnostic devices.

Pentagon targets poorly performing military hospitals, clinics

After a review found wide disparities in the quality of care provided by military-run hospitals and clinics, Defense Secretary Chuck Hagel ordered improvement plans for under-performing facilities. Some parts of the system performed better than in civilian-run ones, but treatment fells short in others.

Finnish researchers gain new insights on brain activity during general anesthesia

Finnish researchers have gained new information on brain activity during general anesthesia by recording changes in the electrical activity of the brain.

Read more Medical News

› Verified 8 days ago